05:29am Friday 10 July 2020

South Asian women should no longer be considered at low risk of breast cancer

Experts from the University’s School of Health and Related Research (ScHARR) in the Faculty of Medicine, Dentistry and Health examined breast cancer rates in the South Asian population in Leicester. Previous studies in the UK have found that incidence of breast cancer is lower in the South Asian population compared to other groups.

Breast cancer data from the National Cancer Registration Service and 2001 census were used to calculate rates of the condition over a 10 year period between 2000 and 2009. Trends were compared between South Asian women and other ethnicities between socioeconomic groups.

Between 2000-2004, South Asian women were found to have a 45 per cent lower rate of breast cancer compared to white women – as found in previous studies.

Radiology technician examines mammography testHowever, by the 2005-2009 period rates of breast cancer among South Asian women had increased significantly and was eight per cent higher than white women, whose rates had not changed over the study period.

Radiology technician examines mammography test

In South Asian women over the age of 65 years, this change was statistically significant with a 37 per cent higher risk of breast cancer than white women.

For all ethnicities combined, rates of breast cancer did not change with socioeconomic deprivation in 2000-2004, but in 2005-2009 it increased with socioeconomic deprivation, contrary to national trends.

Lead study author Matthew Day, Honorary Lecturer in ScHARR, said: “Historically South Asian women, and women in lower socioeconomic groups, have been considered at lower risk of developing breast cancer. Based on our study in Leicester, this should no longer be considered the case.”

He added: “The exact causes behind this change are not clear cut, they could relate to increases in screening uptake among these groups of women, which have in the past been shown to be lower than in other groups. Or they could be due to changes in lifestyle factors, like having fewer children and having them later in life, increased use of oral contraceptives, and increased smoking and alcohol intake – factors linked to increased breast cancer risk across the board.”

Dr Mick Peake, Clinical Lead at Public Health England’s National Cancer Intelligence Network, said: “The results of the Leicester study should assist public health services to both plan for, and respond to, the changing risk profile of breast cancer in the population, particularly with regards Asian women who for a long time have been another group whose attendance rate for screening has been low.

“At the individual level, if women are concerned about breast cancer, they should speak to their GP.”

Additional information

One year survival rates for breast cancer is approximately 95 per cent, and five year survival is around 85 per cent.

Public Health England
Public Health England is a new executive agency of the Department of Health that took up its full responsibilities on 1 April, 2013. PHE works with national and local government, industry and the NHS to protect and improve the nation’s health and support healthier choices and will be addressing inequalities by focusing on removing barriers to good health. To find out more visit our website www.gov.uk/phe, follow us on Twitter @PHE_uk.

National Cancer Intelligence Network (NCIN), operated by Public Health England
The NCIN was established in June 2008 to coordinate the collection, analysis and publication of comparative national statistics on diagnosis, treatment and outcomes for all types of cancer The NCIN is a UK wide partnership funded by multiple stakeholders. The NCIN will drive improvements in the standards of care and clinical outcomes through exploiting data.
The NCIN will support audit and research programmes by providing cancer information and patient care will be monitored through expert analyses of up-to-date statistics. For more information please visit www.ncin.org.uk and www.gov.uk/phe

The University of Sheffield
With nearly 25,000 of the brightest students from 117 countries coming to learn alongside 1,209 of the world’s best academics, it is clear why the University of Sheffield is one of the UK’s leading universities. Staff and students at Sheffield are committed to helping discover and understand the causes of things – and propose solutions that have the power to transform the world we live in.

A member of the Russell Group, the University of Sheffield has a reputation for world-class teaching and research excellence across a wide range of disciplines. The University of Sheffield has been named University of the Year in the Times Higher Education Awards 2011 for its exceptional performance in research, teaching, access and business performance. In addition, the University has won four Queen’s Anniversary Prizes (1998, 2000, 2002, 2007), recognising the outstanding contribution by universities and colleges to the United Kingdom’s intellectual, economic, cultural and social life.

One of the markers of a leading university is the quality of its alumni and Sheffield boasts five Nobel Prize winners among former staff and students. Its alumni have gone on to hold positions of great responsibility and influence all over the world, making significant contributions in their chosen fields.

Research partners and clients include Boeing, Rolls-Royce, Unilever, Boots, AstraZeneca, GSK, Siemens, Yorkshire Water and many more household names, as well as UK and overseas government agencies and charitable foundations.

The University has well-established partnerships with a number of universities and major corporations, both in the UK and abroad. The White Rose University Consortium (White Rose) a strategic partnership between three of the UK’s leading research universities of Leeds, Sheffield and York. Since its creation in 1997 White Rose has secured more than £100M into the Universities.

For further information, please visit www.sheffield.ac.uk


Share on:
or:

MORE FROM Breast Cancer

Health news